Abstract
CD1, a conserved family of major histocompatibility (MHC)-like glycoproteins in mammals, specializes in capturing lipid rather than peptide antigen for presentation to T lymphocytes. The principles and mechanisms of this newly discovered immune strategy differ markedly from those governing classical MHC-peptide presentation. They might be exploited for the design of new lipid-based microbial vaccines and adjuvants.
| Original language | English |
|---|---|
| Pages (from-to) | 788-792 |
| Number of pages | 5 |
| Journal | Nature |
| Volume | 406 |
| Issue number | 6797 |
| DOIs | |
| Publication status | Published - 2000 Aug 17 |
| Externally published | Yes |
ASJC Scopus subject areas
- General